Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, February 24, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Michael Ulz Maintained (ALNY) at Hold with Decreased Target to $205 on, Feb 24th, 2023
Michael Ulz of Morgan Stanley, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold with Decreased Target from $210 to $205 on, Feb 24th, 2023.
Michael has made no other calls on ALNY in the last 4 months.
There are 7 other peers that have a rating on ALNY. Out of the 7 peers that are also analyzing ALNY, 3 agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Mani Foroohar of "SVB Leerink" Maintained at Hold with Decreased Target to $143 on, Monday, January 23rd, 2023
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $210 on, Friday, October 28th, 2022
- Jessica Fye of "JP Morgan" Maintained at Hold with Decreased Target to $200 on, Monday, October 24th, 2022
These are the ratings of the 4 analyists that currently disagree with Michael
- Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $253 on, Friday, December 16th, 2022
- Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $415 on, Wednesday, November 2nd, 2022
- Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $270 on, Friday, October 28th, 2022
- Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $236 on, Friday, October 28th, 2022
